Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
170.9 BRL | -1.20% |
|
+1.13% | +82.96% |
02:35pm | Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793 | MT |
09:00am | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
Official Publications
SEC Filing 8K | CO | |
Dividends | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 10Q-1 | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
Changes in management and corporate officers | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
3rd quarter results | CO |
- Stock Market
- Equities
- LLY Stock
- LILY34 Stock
- News Eli Lilly and Company
- Official Publications